ConductScience.org, home

Paper2024958

Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center.

Muder RR and 4 others. Antimicrob Agents Chemother, 1991. Cited by 97 papers, by iCite.

Cite this record

ConductScience Library. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center. Papers, record 2024958. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2024958

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
97
iCite
Relative citation ratio, by iCite
5.44
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Muder RRR R
2Brennen CC
3Goetz AMA M
4Wagener MMM M
5Rihs JDJ D

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
CiprofloxacinMajor topic
Gram-Negative BacteriaMajor topic
Bacterial Infections
Drug Resistance, Microbial
Hospitals, Veterans
Humans
Microbial Sensitivity Tests
Risk Factors
United States
United States Department of Veterans Affairs

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17266615Infections among patients in nursing homes: policies, prevalence, problems.N Engl J Med1981https://conductscience.org/library/papers/7266615PubMed
22158277Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2158277PubMed
36736514A prospective study of nosocomial infections in a chronic care facility.J Am Geriatr Soc1984https://conductscience.org/library/papers/6736514PubMed
43929707Antibiotic-resistant flora in nursing home patients admitted to the hospital.Arch Intern Med1985https://conductscience.org/library/papers/3929707PubMed
53934102Infection control programs in twelve North Carolina extended care facilities.Infect Control1985https://conductscience.org/library/papers/3934102PubMed
63512733Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens.J Infect Dis1986https://conductscience.org/library/papers/3512733PubMed
73632167High-level aminoglycoside-resistant enterococci. Colonization of nursing home and acute care hospital patients.Arch Intern Med1987https://conductscience.org/library/papers/3632167PubMed
83341858High rate of methicillin resistance of Staphylococcus aureus isolated from hospitalized nursing home patients.Arch Intern Med1988https://conductscience.org/library/papers/3341858PubMed
92837141Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/2837141PubMed
102841893CDC definitions for nosocomial infections, 1988.Am J Infect Control1988https://conductscience.org/library/papers/2841893PubMed
113142353Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3142353PubMed
122719462Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2719462PubMed
132680058Fluoroquinolone antimicrobial agents.Clin Microbiol Rev1989https://conductscience.org/library/papers/2680058PubMed
142514623Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2514623PubMed
152183709In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2183709PubMed
166562089Urinary tract infections with antibiotic resistant organisms in catheterized nursing home patients.Infect Control1984https://conductscience.org/library/papers/6562089PubMed

Download CSV of references

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 97 citations.

PMIDTitleJournalYearIn PapersSource
26634119
Implementation of an antimicrobial stewardship program targeting residents with urinary tract infections in three community long-term care facilities: a quasi-experimental study using time-series analysis.
Antimicrob Resist Infect Control2015https://conductscience.org/library/papers/26634119PubMed
26072936Prevalence of and risk factors for multidrug-resistant Acinetobacter baumannii colonization among high-risk nursing home residents.Infect Control Hosp Epidemiol2015https://conductscience.org/library/papers/26072936PubMed
25278932Understanding the patterns of antibiotic susceptibility of bacteria causing urinary tract infection in West Bengal, India.Front Microbiol2014https://conductscience.org/library/papers/25278932PubMed
23986544Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities.J Infect Dis2014https://conductscience.org/library/papers/23986544PubMed
23956373Risk factors and clinical characteristics of patients with qnr-positive Klebsiella pneumoniae bacteraemia.J Antimicrob Chemother2013https://conductscience.org/library/papers/23956373PubMed
22805801Ciprofloxacin-resistant Escherichia coli in hospital wastewater of Bangladesh and prediction of its mechanism of resistance.World J Microbiol Biotechnol2012https://conductscience.org/library/papers/22805801PubMed
16723572
Using interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16723572PubMed
16150741Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial.BMJ2005https://conductscience.org/library/papers/16150741PubMed
15963284Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility.Emerg Infect Dis2005https://conductscience.org/library/papers/15963284PubMed
15931454Impact of a fluoroquinolone formulary change on acquisition of quinolone-resistant gram-negative bacilli.Eur J Clin Microbiol Infect Dis2005https://conductscience.org/library/papers/15931454PubMed
15207056Nursing home residents and Enterobacteriaceae resistant to third-generation cephalosporins.Emerg Infect Dis2004https://conductscience.org/library/papers/15207056PubMed
15155181The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15155181PubMed
12207826Optimizing antibiotics in residents of nursing homes: protocol of a randomized trial.BMC Health Serv Res2002https://conductscience.org/library/papers/12207826PubMed
12110157Application of the development stages of a cluster randomized trial to a framework for valuating complex health interventions.BMC Health Serv Res2002https://conductscience.org/library/papers/12110157PubMed
12064813Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence.Dig Dis Sci2002https://conductscience.org/library/papers/12064813PubMed
11709313Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11709313PubMed
11422634Antibiotic use in Ontario facilities that provide chronic care.J Gen Intern Med2001https://conductscience.org/library/papers/11422634PubMed
11302820Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.Antimicrob Agents Chemother2001https://conductscience.org/library/papers/11302820PubMed
10543756Emergence and dissemination of quinolone-resistant Escherichia coli in the community.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10543756PubMed
9796662Emergence and infectious complications of ciprofloxacin-resistant Escherichia coli in haematological cancer patients.Eur J Clin Microbiol Infect Dis1998https://conductscience.org/library/papers/9796662PubMed

See all 38 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2024958

GET https://conductscience.org/api/papers/v1/2024958/cited_by?page=2